OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumors
RNA-seq (gene expression) · human · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 36 samples: 12 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumoursNature · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE310267_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1365650 and SRA study SRP645967. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 36 samples.
How we read this: 12 replicated groups read from 36 sample titles; they account for 36 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9293097 HER2CAR_OR7A10_0hr_Rep1 HER2CAR_OR7A10_0hr
- GSM9293098 HER2CAR_OR7A10_0hr_Rep2 HER2CAR_OR7A10_0hr
- GSM9293099 HER2CAR_OR7A10_0hr_Rep3 HER2CAR_OR7A10_0hr
- GSM9293100 HER2CAR_OR7A10_24hr_Rep1 HER2CAR_OR7A10_24hr
- GSM9293101 HER2CAR_OR7A10_24hr_Rep2 HER2CAR_OR7A10_24hr
- GSM9293102 HER2CAR_OR7A10_24hr_Rep3 HER2CAR_OR7A10_24hr
- GSM9293103 HER2CAR_OR7A10Stop_0hr_Rep1 HER2CAR_OR7A10Stop_0hr
- GSM9293104 HER2CAR_OR7A10Stop_0hr_Rep2 HER2CAR_OR7A10Stop_0hr
- GSM9293105 HER2CAR_OR7A10Stop_0hr_Rep3 HER2CAR_OR7A10Stop_0hr
- GSM9293106 HER2CAR_OR7A10Stop_24hr_Rep1 HER2CAR_OR7A10Stop_24hr
- GSM9293107 HER2CAR_OR7A10Stop_24hr_Rep2 HER2CAR_OR7A10Stop_24hr
- GSM9293108 HER2CAR_OR7A10Stop_24hr_Rep3 HER2CAR_OR7A10Stop_24hr
- GSM9293109 OR7A10_0hr_Rep1 OR7A10_0hr
- GSM9293110 OR7A10_0hr_Rep2 OR7A10_0hr
- GSM9293111 OR7A10_0hr_Rep3 OR7A10_0hr
- GSM9293112 OR7A10_24hr_Rep1 OR7A10_24hr
- GSM9293113 OR7A10_24hr_Rep2 OR7A10_24hr
- GSM9293114 OR7A10_24hr_Rep3 OR7A10_24hr
- GSM9293115 OR7A10Stop_0hr_Rep1 OR7A10Stop_0hr
- GSM9293116 OR7A10Stop_0hr_Rep2 OR7A10Stop_0hr
- GSM9293117 OR7A10Stop_0hr_Rep3 OR7A10Stop_0hr
- GSM9293118 OR7A10Stop_24hr_Rep1 OR7A10Stop_24hr
- GSM9293119 OR7A10Stop_24hr_Rep2 OR7A10Stop_24hr
- GSM9293120 OR7A10Stop_24hr_Rep3 OR7A10Stop_24hr
- GSM9293121 tHER2CAR_OR7A10_0hr_Rep1 tHER2CAR_OR7A10_0hr
- GSM9293122 tHER2CAR_OR7A10_0hr_Rep2 tHER2CAR_OR7A10_0hr
- GSM9293123 tHER2CAR_OR7A10_0hr_Rep3 tHER2CAR_OR7A10_0hr
- GSM9293124 tHER2CAR_OR7A10_24hr_Rep1 tHER2CAR_OR7A10_24hr
- GSM9293125 tHER2CAR_OR7A10_24hr_Rep2 tHER2CAR_OR7A10_24hr
- GSM9293126 tHER2CAR_OR7A10_24hr_Rep3 tHER2CAR_OR7A10_24hr
- GSM9293127 tHER2CAR_OR7A10Stop_0hr_Rep1 tHER2CAR_OR7A10Stop_0hr
- GSM9293128 tHER2CAR_OR7A10Stop_0hr_Rep2 tHER2CAR_OR7A10Stop_0hr
- GSM9293129 tHER2CAR_OR7A10Stop_0hr_Rep3 tHER2CAR_OR7A10Stop_0hr
- GSM9293130 tHER2CAR_OR7A10Stop_24hr_Rep1 tHER2CAR_OR7A10Stop_24hr
- GSM9293131 tHER2CAR_OR7A10Stop_24hr_Rep2 tHER2CAR_OR7A10Stop_24hr
- GSM9293132 tHER2CAR_OR7A10Stop_24hr_Rep3 tHER2CAR_OR7A10Stop_24hr
- GSE309802 OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumors 78 samples shares or7a10, car-nk, gpcr, engineering, therapy, against, boosts, solid
- GSE288846 Engineering a novel HSV-1 strain for oncolytic therapy of solid tumors 16 samples shares engineering, therapy, solid
- GSE255046 A Repressive Type of TEAD4 Condensation and Engineering a Glue Peptide Therapy Against Cancer [RNA-Seq_TEAD4KO] 12 samples shares engineering, therapy, against
- GSE255045 A Repressive Type of TEAD4 Condensation and Engineering a Glue Peptide Therapy Against Cancer [RNA-Seq399] 6 samples shares engineering, therapy, against
- GSE301774 Engineering a Reversible Plant Hormone–Inducible ON-Switch Boosts Safety and Potency of CAR-T Cell Immunotherapy 4 samples shares engineering, therapy, boosts
- GSE244417 A Repressive Type of TEAD4 Condensation and Engineering a Glue Peptide Therapy Against Cancer [RNA-Seq] 4 samples shares engineering, therapy, against
- GSE244420 A Repressive Type of TEAD4 Condensation and Engineering a Glue Peptide Therapy Against Cancer 14 samples shares engineering, therapy, against
- GSE274201 A Repressive Type of TEAD4 Condensation and Engineering a Glue Peptide Therapy Against Cancer [Cut&Tag_T4] 11 samples shares engineering, therapy, against
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.